BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seoane S, Arias E, Sigueiro R, Sendon-Lago J, Martinez-Ordoñez A, Castelao E, Eiró N, Garcia-Caballero T, Macia M, Lopez-Lopez R, Maestro M, Vizoso F, Mouriño A, Perez-Fernandez R. Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment. Oncotarget 2015;6:14456-71. [PMID: 25992773 DOI: 10.18632/oncotarget.3894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang YY, Hung AC, Lo S, Hsieh YC, Yuan SF. MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy. Cancer Lett 2021;514:1-11. [PMID: 34022282 DOI: 10.1016/j.canlet.2021.05.013] [Reference Citation Analysis]
2 Martínez-Ordoñez A, Seoane S, Avila L, Eiro N, Macía M, Arias E, Pereira F, García-Caballero T, Gómez-Lado N, Aguiar P, Vizoso F, Perez-Fernandez R. POU1F1 transcription factor induces metabolic reprogramming and breast cancer progression via LDHA regulation. Oncogene 2021;40:2725-40. [PMID: 33714987 DOI: 10.1038/s41388-021-01740-6] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
3 Agarwal S, Cho TY. Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter. Nucleic Acids Res 2018;46:929-41. [PMID: 29186613 DOI: 10.1093/nar/gkx1183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Wang H, Huang Y, Shi J, Zhi Y, Yuan F, Yu J, Chen Z, Yang J. XPC deficiency leads to centrosome amplification by inhibiting BRCA1 expression upon cisplatin-mediated DNA damage in human bladder cancer. Cancer Lett 2019;444:136-46. [PMID: 30579971 DOI: 10.1016/j.canlet.2018.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Sun CY, Zhang QY, Zheng GJ, Feng B. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomed Pharmacother 2019;110:518-27. [PMID: 30530287 DOI: 10.1016/j.biopha.2018.12.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
6 Feltes BC. Architects meets Repairers: The interplay between homeobox genes and DNA repair. DNA Repair (Amst) 2019;73:34-48. [PMID: 30448208 DOI: 10.1016/j.dnarep.2018.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhu L, Zou J, Zhao Y, Jiang X, Wang Y, Wang X, Chen B. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. J Exp Clin Cancer Res 2018;37:123. [PMID: 29940998 DOI: 10.1186/s13046-018-0798-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gogoi P, Seoane S, Sigüeiro R, Guiberteau T, Maestro MA, Pérez-fernández R, Rochel N, Mouriño A. Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists. J Med Chem 2018;61:4928-37. [DOI: 10.1021/acs.jmedchem.8b00337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Martinez-Ordoñez A, Seoane S, Cabezas P, Eiro N, Sendon-Lago J, Macia M, Garcia-Caballero T, Gonzalez LO, Sanchez L, Vizoso F, Perez-Fernandez R. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis. Oncogene 2018;37:1430-44. [PMID: 29321662 DOI: 10.1038/s41388-017-0036-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 8.3] [Reference Citation Analysis]
10 Gao Z, Xue K, Zhang L, Wei M. Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients. Med Sci Monit 2016;22:4121-5. [PMID: 27798557 DOI: 10.12659/msm.896107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]